Skip to search formSkip to main contentSkip to account menu

enalkiren

Known as: (Alpha-S)-Alpha-((Alpha-S)-Alpha-(3-Amino-3-Methylbutyramido)-p-Methoxyhydrocinnamamido)-N-((1S,2R,3S)-1-(Cyclohexylmethyl)-2,3-Dihydroxy-5-Methylhexyl)Imidazole-4-Propionamide, (N-(3-amino-3-methyl-1-oxobutyl)-4-methoxy-L-phenylalanyl)-N-(1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-L-histidinamide, L-Histidinamide, N-(3-amino-3-methyl-1-oxobutyl)-O-methyl-L-tyrosyl-N-(1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-, (1S-(1R*,2S*,3R*))- 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

A 64662

Broader (2)

DipeptidesProtease Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Renin inhibitor in hypertension treatment: from pharmacological point of view
The use of drugs that inhibit the renin-angiotensin system is one of the effective way to intervene in the pathogenesis of… 
1990
1990
Profile of the Renin Inhibitor, Enalkiren (ABBOTT‐64662)